Cargando…

Independence estimators for re-randomisation trials in multi-episode settings: a simulation study

BACKGROUND: Re-randomisation trials involve re-enrolling and re-randomising patients for each new treatment episode they experience. They are often used when interest lies in the average effect of an intervention across all the episodes for which it would be used in practice. Re-randomisation trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahan, Brennan C., White, Ian R., Eldridge, Sandra, Hooper, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557515/
https://www.ncbi.nlm.nih.gov/pubmed/34717559
http://dx.doi.org/10.1186/s12874-021-01433-4
_version_ 1784592387403677696
author Kahan, Brennan C.
White, Ian R.
Eldridge, Sandra
Hooper, Richard
author_facet Kahan, Brennan C.
White, Ian R.
Eldridge, Sandra
Hooper, Richard
author_sort Kahan, Brennan C.
collection PubMed
description BACKGROUND: Re-randomisation trials involve re-enrolling and re-randomising patients for each new treatment episode they experience. They are often used when interest lies in the average effect of an intervention across all the episodes for which it would be used in practice. Re-randomisation trials are often analysed using independence estimators, where a working independence correlation structure is used. However, research into independence estimators in the context of re-randomisation has been limited. METHODS: We performed a simulation study to evaluate the use of independence estimators in re-randomisation trials. We focussed on a continuous outcome, and the setting where treatment allocation does not affect occurrence of subsequent episodes. We evaluated different treatment effect mechanisms (e.g. by allowing the treatment effect to vary across episodes, or to become less effective on re-use, etc), and different non-enrolment mechanisms (e.g. where patients who experience a poor outcome are less likely to re-enrol for their second episode). We evaluated four different independence estimators, each corresponding to a different estimand (per-episode and per-patient approaches, and added-benefit and policy-benefit approaches). RESULTS: We found that independence estimators were unbiased for the per-episode added-benefit estimand in all scenarios we considered. We found independence estimators targeting other estimands (per-patient or policy-benefit) were unbiased, except when there was differential non-enrolment between treatment groups (i.e. when different types of patients from each treatment group decide to re-enrol for subsequent episodes). We found the use of robust standard errors provided close to nominal coverage in all settings where the estimator was unbiased. CONCLUSIONS: Careful choice of estimand can ensure re-randomisation trials are addressing clinically relevant questions. Independence estimators are a useful approach, and should be considered as the default estimator until the statistical properties of alternative estimators are thoroughly evaluated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-021-01433-4.
format Online
Article
Text
id pubmed-8557515
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85575152021-11-01 Independence estimators for re-randomisation trials in multi-episode settings: a simulation study Kahan, Brennan C. White, Ian R. Eldridge, Sandra Hooper, Richard BMC Med Res Methodol Research BACKGROUND: Re-randomisation trials involve re-enrolling and re-randomising patients for each new treatment episode they experience. They are often used when interest lies in the average effect of an intervention across all the episodes for which it would be used in practice. Re-randomisation trials are often analysed using independence estimators, where a working independence correlation structure is used. However, research into independence estimators in the context of re-randomisation has been limited. METHODS: We performed a simulation study to evaluate the use of independence estimators in re-randomisation trials. We focussed on a continuous outcome, and the setting where treatment allocation does not affect occurrence of subsequent episodes. We evaluated different treatment effect mechanisms (e.g. by allowing the treatment effect to vary across episodes, or to become less effective on re-use, etc), and different non-enrolment mechanisms (e.g. where patients who experience a poor outcome are less likely to re-enrol for their second episode). We evaluated four different independence estimators, each corresponding to a different estimand (per-episode and per-patient approaches, and added-benefit and policy-benefit approaches). RESULTS: We found that independence estimators were unbiased for the per-episode added-benefit estimand in all scenarios we considered. We found independence estimators targeting other estimands (per-patient or policy-benefit) were unbiased, except when there was differential non-enrolment between treatment groups (i.e. when different types of patients from each treatment group decide to re-enrol for subsequent episodes). We found the use of robust standard errors provided close to nominal coverage in all settings where the estimator was unbiased. CONCLUSIONS: Careful choice of estimand can ensure re-randomisation trials are addressing clinically relevant questions. Independence estimators are a useful approach, and should be considered as the default estimator until the statistical properties of alternative estimators are thoroughly evaluated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-021-01433-4. BioMed Central 2021-10-30 /pmc/articles/PMC8557515/ /pubmed/34717559 http://dx.doi.org/10.1186/s12874-021-01433-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kahan, Brennan C.
White, Ian R.
Eldridge, Sandra
Hooper, Richard
Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
title Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
title_full Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
title_fullStr Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
title_full_unstemmed Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
title_short Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
title_sort independence estimators for re-randomisation trials in multi-episode settings: a simulation study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557515/
https://www.ncbi.nlm.nih.gov/pubmed/34717559
http://dx.doi.org/10.1186/s12874-021-01433-4
work_keys_str_mv AT kahanbrennanc independenceestimatorsforrerandomisationtrialsinmultiepisodesettingsasimulationstudy
AT whiteianr independenceestimatorsforrerandomisationtrialsinmultiepisodesettingsasimulationstudy
AT eldridgesandra independenceestimatorsforrerandomisationtrialsinmultiepisodesettingsasimulationstudy
AT hooperrichard independenceestimatorsforrerandomisationtrialsinmultiepisodesettingsasimulationstudy